Mol-Zero-GAN: zero-shot adaptation of molecular generative adversarial network for specific protein targets

Abstract

A framework that optimizes the drug generative adversarial network (GAN) to produce drugs targeting specific proteins, while preserving drug-likeness using Bayesian optimization and singular value decomposition (SVD).